188re-sss lipiodol
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2010 (NCT01126463)
Timeline
Indications
Studied for
Mechanism of action
- Unspecified targetRadiodepletion
radiodepletion
Chemistry & pharmacology
- Payload
- 188-rhenium
Oral
No
Parenteral
No
Topical
No
Also known as
- 188re-sss lipiodol
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05797870 | Phase 2 | Feb 15, 2024 | Center Eugene Marquis |
| NCT01126463 | Phase 1 | May 1, 2010 | Center Eugene Marquis, University of Rennes |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Center Eugene Marquis | Academic/Hospital | 2 | 2 | 2 | 2010 |
| University of Rennes | Academic/Hospital | 1 | 0 | 1 | 2010 |
2 organizations
Page 1 / 1